Microhematuria (3+ RBCs on Dipstick): Risk Stratification and Workup
A urine dipstick showing 3+ red blood cells requires confirmation with microscopic urinalysis showing ≥3 RBCs per high-power field before initiating any urologic evaluation, followed by risk-stratified workup based on age, sex, smoking history, and degree of hematuria. 1
Initial Confirmation and Assessment
Do not proceed with urologic workup based on dipstick alone – dipstick hematuria must be confirmed by microscopic urinalysis demonstrating ≥3 RBCs/HPF on a properly collected, non-contaminated specimen without evidence of infection. 1 Dipstick-only evaluation leads to unnecessary consultations and costly workups in up to 76% of referred patients. 2
Exclude Benign Causes First
Before any imaging or cystoscopy, rule out: 1
- Urinary tract infection (obtain urine culture before antibiotics if suspected)
- Menstruation
- Vigorous exercise
- Recent urologic procedure or trauma
- Renal parenchymal disease (check for proteinuria, casts, elevated creatinine – if present, concurrent nephrology evaluation is needed but does not preclude urologic workup)
Important caveat: Anticoagulation therapy does NOT alter the need for evaluation – these patients still require full workup. 1
Risk Stratification System
The 2025 AUA/SUFU guidelines validate a three-tier risk stratification that determines the intensity of evaluation: 1
Low/Negligible Risk (Cancer risk: 0%)
- Women under age 60 without other risk factors
- No evaluation required in this group based on validation studies showing zero malignancies detected 1
Intermediate Risk (Cancer risk: 3.1%)
- Patients with microhematuria and some risk factors but not meeting high-risk criteria
- Requires imaging and cystoscopy 1
High Risk (Cancer risk: 6.3% overall; 10.9% if gross hematuria present)
- Age considerations: Women ≥60 years, men >35 years 1
- Smoking history (quantify pack-years; includes combustible tobacco)
- Occupational chemical exposure
- Gross hematuria (visible blood – associated with 30-40% malignancy risk)
- History of pelvic irradiation
- Chronic UTI or indwelling foreign body
- Irritative voiding symptoms
- Prior urologic disease
- Analgesic abuse or chemotherapy exposure 1
Critical finding: Among high-risk patients, those with gross hematuria have 4-fold higher cancer detection (10.9%) compared to isolated microhematuria (2.6%). 1
Workup Algorithm
History and Physical Examination
- Smoking history: Document pack-years and all tobacco products (assist with cessation) 1
- Blood pressure measurement 1
- Genitourinary examination: Pelvic exam in women, rectal exam in men 1
- Consider interstitial cystitis in women with chronic pelvic pain and microhematuria 1
Imaging
For intermediate and high-risk patients: 1
- CT urography (CTU) is the preferred imaging modality
- Includes unenhanced images plus nephrographic and excretory phases (≥5 minutes post-contrast)
- Thin-slice acquisition with multiplanar reconstruction
- Evaluates both upper and lower urinary tracts
Alternative: MR urography if CT contraindicated (renal insufficiency, contrast allergy, pregnancy) 1
Key validation data: Nearly 70% of malignancies in women with microhematuria were renal (upper tract), emphasizing the importance of complete urinary tract imaging. 1
Cystoscopy
Required for intermediate and high-risk patients in addition to imaging. 1 The combination of imaging and cystoscopy is necessary because imaging alone may miss bladder lesions, particularly flat urothelial carcinoma. 1
Eliminate Voided Urinary Cytology
Voided cytology should NOT be part of routine screening – it lacks sufficient sensitivity to obviate further workup if negative and adds unnecessary cost. 3
Common Pitfalls
Referring based on dipstick alone: 59% of patients referred for "hematuria" lack confirmed microscopic hematuria, resulting in $44,901 in unnecessary Medicare costs per 69 patients. 2
Over-evaluating young women: Women under 60 without risk factors have essentially zero cancer risk and should not undergo invasive workup. 1
Assuming anticoagulation explains hematuria: These patients still require full evaluation. 1
Missing the degree of hematuria: Interestingly, 12 of 13 malignancies in one validation study occurred in women with only 3-10 RBCs/HPF (not higher grades), indicating that lower degrees of microhematuria still warrant evaluation when other risk factors are present. 1
Ignoring smoking cessation: Provide evidence-based cessation resources as part of the evaluation. 1